It’s no April Fools’ joke. On April 1, 2019, the Health Resources & Services Administration Office of Pharmacy Affairs (“HRSA”) unveiled a long-awaited website that gives providers participating in the 340B drug pricing program (“340B Program”) direct access to information about the maximum amounts that pharmaceutical companies may charge for certain drugs. This moves... READ MORE
The 340B Crystal Ball: New Clarity on 340B Prices and the Program’s Future
Posted on April 5, 2019 in Health Law News
Published by: Hall Render
